Future Opportunities in Drug Development: American Society for Clinical Pharmacology and Therapeutics Pharmacometrics and Pharmacokinetics Community Vision
Year: 2023
Type: article
Abstract: The authors declared no competing interests for this work. As an Associate Editor for Clinical Pharmacology & Therapeutics, Karthik Venkatakrishnan was not involved in the review or decision process for this paper.
DOI: 10.1002/cpt.2955
Institutions: Biogen (United States), United States Food and Drug Administration, Center for Drug Evaluation and Research, AbbVie (United States), Amgen (United States), Takeda (United States), Genentech, University of Florida, Merck KGaA, Darmstadt (Germany), EMD Serono, Inc. (United States), Merck Healthcare KGaA, Darmstadt (Germany), AstraZeneca (United States)
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W4380244145